Aberrant ROS Mediate Cell Cycle and Motility in Colorectal Cancer Cells Through an Oncogenic CXCL14 Signaling Pathway.

Zeng, Jun; Li, Mei; Xu, Jun-Yu; Xiao, Heng; Yang, Xian; Fan, Jiao-Xiu; Wu, Kang; Chen, Shuang

Zeng, Jun; Li, Mei; Xu, Jun-Yu; Xiao, Heng; Yang, Xian; Fan, Jiao-Xiu; Wu, Kang; Chen, Shuang.

Afiliación

Zeng J; Department of Genetics and Cell Biology, College of Life Sciences, Chongqing Normal University, Chongqing, China.
Li M; Department of Genetics and Cell Biology, College of Life Sciences, Chongqing Normal University, Chongqing, China.
Xu JY; Department of Genetics and Cell Biology, College of Life Sciences, Chongqing Normal University, Chongqing, China.
Xiao H; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yang X; Department of Genetics and Cell Biology, College of Life Sciences, Chongqing Normal University, Chongqing, China.
Fan JX; Department of Genetics and Cell Biology, College of Life Sciences, Chongqing Normal University, Chongqing, China.
Wu K; Shenzhen Luohu People's Hospital, the Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
Chen S; South China Hospital, Shenzhen University, Shenzhen, China.

Front Pharmacol ; 12: 764015, 2021.

Article en En | MEDLINE | ID: mdl-34744744

Palabras clave

CXCL14; ROS; cell cycle; colorectal cancer; migration

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: China